Disentangling the relationship between tumor genetic programs and immune responsiveness.
Disentangling the relationship between tumor genetic programs and immune responsiveness.
D. Bedognetti,W. Hendrickx,2 Authors,B. Seliger
2016 · DOI: 10.1016/j.coi.2016.02.001
Current Opinion in Immunology · 52 Citations
TLDR
Inhibiting oncogenic pathways that prevent the development of the immune-favorable cancer phenotype may complement modern immunotherapeutic approaches.